Reversible posterior leukoencephalopathy syndrome induced by sunitinib.
German
G
Martín
Lorena
L
Bellido
Juan Jesus
JJ
Cruz
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000556:secondary; D001921:Brain / Q000473:pathology; D001927:Brain Diseases / Q000139:chemically induced* / Q000175:diagnosis*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D009362:Neoplasm Metastasis; D011758:Pyrroles / Q000009:adverse effects*; D012640:Seizures / Q000139:chemically induced; D000077210:Sunitinib; D013577:Syndrome; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib